US Broker Ratings

Royalty Pharma plc (RPRX) Stock Analysis: A Robust Biopharma Royalty Player with a Potential 12.94% Upside

Royalty Pharma plc (NASDAQ: RPRX) is a compelling player in the biopharmaceutical industry, strategically positioned as a major buyer of biopharmaceutical royalties and a financier of..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: A Compelling 86.73% Potential Upside in the Medical Device Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) is positioned as a noteworthy player in the healthcare sector, particularly within the medical devices industry. The company specializes in digital..

Waystar Holding Corp. (WAY) Stock Analysis: Navigating a 52.21% Potential Upside with Robust Revenue Growth

Waystar Holding Corp. (WAY), a pivotal player in the Healthcare sector specializing in Health Information Services, presents a compelling case for investors seeking opportunities in the..

Fresenius Medical Care AG (FMS) Stock Analysis: Unpacking the 18.65% Potential Upside

Fresenius Medical Care AG (NYSE: FMS), a key player in the healthcare sector, stands as a global leader in providing dialysis and related services. Headquartered in..

Stryker Corporation (SYK) Stock Analysis: Evaluating a 26% Potential Upside in the Medical Device Sector

For investors navigating the healthcare sector, Stryker Corporation (NYSE: SYK) represents a compelling opportunity with a potential upside of over 26%, according to analyst ratings. As..

Danaher Corporation (DHR) Stock Analysis: A 41% Upside Potential for Healthcare Investors

Investors looking to capitalize on the healthcare sector should certainly pay attention to Danaher Corporation (NYSE: DHR). With a substantial market capitalization of $132.46 billion, this..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Strong Buy Ratings and 45.82% Potential Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI) is capturing investor attention with its substantial potential upside and a suite of strong buy ratings from analysts. This Utah-based..

Tempus AI, Inc. (TEM) Stock Analysis: Exploring a Promising 55.92% Potential Upside

Tempus AI, Inc. (NASDAQ: TEM) has captured the attention of investors with its significant growth potential, underscored by a remarkable 55.92% potential upside, according to analyst..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a Potential 209.82% Upside in the Biotech Sector

Legend Biotech Corporation (NASDAQ: LEGN), a prominent player in the biotechnology sector, is capturing investor attention with its promising pipeline of novel cell therapies and an..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 24.72% Potential Upside Worth Watching

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, continues to capture investor attention with its robust pipeline of pharmaceutical products and a..

Viatris Inc. (VTRS) Stock Analysis: Understanding the 14.73% Potential Upside for Investors

Viatris Inc. (VTRS), with its substantial market cap of $15.56 billion, is a noteworthy player in the healthcare sector, particularly in the specialty and generic drug..

Repligen Corporation (RGEN) Stock Analysis: A Promising 62.63% Upside in the Bioprocessing Space

Repligen Corporation (NASDAQ: RGEN), a key player in the healthcare sector, particularly in medical instruments and supplies, is poised for notable growth according to analysts. The..

Guardant Health, Inc. (GH) Stock Analysis: A 55% Potential Upside Awaits in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH), a trailblazer in the precision oncology space, is capturing investor attention with its innovative approach to cancer diagnostics and a compelling..

Avantor, Inc. (AVTR) Stock Analysis: Exploring a Potential 36.91% Upside Amidst Market Challenges

Avantor, Inc. (NYSE: AVTR) stands as a formidable entity within the healthcare sector, specifically in the niche of medical instruments and supplies. With a market capitalization..

Stevanato Group S.p.A. (STVN) Stock Analysis: Healthcare Innovator with a 69.82% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN), a stalwart in the healthcare sector, specifically within the Medical Instruments & Supplies industry, presents a compelling investment opportunity with a..

Bruker Corporation (BRKR): Investor Outlook Reveals 43% Potential Upside Amid Healthcare Sector Challenges

Investors eyeing the healthcare sector might find Bruker Corporation (BRKR) an intriguing opportunity, as the company showcases a potential upside of 43.49% based on analyst ratings...

Encompass Health Corporation (EHC) Stock Analysis: Exploring a 42% Potential Upside with Strong Buy Ratings

Encompass Health Corporation (NYSE: EHC), a prominent entity in the healthcare sector specializing in medical care facilities, is capturing investor attention with its impressive growth prospects..

Regencell Bioscience Holdings (RGC) Stock Analysis: Unraveling the Prospects of a $11.49 Billion TCM Innovator

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is a healthcare entity based in Hong Kong, making strides in the specialized field of Traditional Chinese Medicine (TCM). With..

Ionis Pharmaceuticals (IONS): Investor Outlook Reveals 31.90% Potential Upside Despite Challenging Metrics

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands as a prominent player in the biotechnology sector, with its focus on RNA-targeted medicines. Headquartered in Carlsbad, California, Ionis is..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 13.28% Upside Potential

Biogen Inc. (BIIB), a stalwart in the healthcare sector, primarily engages in the discovery and development of therapies for a range of neurological and autoimmune conditions...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds